Home › Funds › Eurizon Capital SGR S.p.A. › LLY
Eurizon Capital SGR S.p.A. position in LLY
Eli Lilly & Co · Health Care
Eurizon Capital SGR S.p.A. reported holding 417,655 shares of LLY (Eli Lilly & Co) in its Q3 2026 13F filing — a position valued at US$485.6M, representing 1.29% of its reported portfolio and ranking #14 among its reported holdings. Eurizon Capital SGR S.p.A. has disclosed LLY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR
How Eurizon Capital SGR S.p.A.'s LLY position evolved
Eurizon Capital SGR S.p.A. first disclosed a stake in LLY in Q4 2025 at 528,895 shares (US$568.8M). Across 4 filings, Eurizon Capital SGR S.p.A. increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 417,655 shares valued at US$485.6M — a reduction of -11,495 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 528.89K | $568.77M | New |
| Q1 2026 | 441.21K | $403.02M | Reduce |
| Q2 2026 | 429.15K | $517.30M | Reduce |
| Q3 2026 | 417.65K | $485.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LLY and 13F data
LLY (Eli Lilly & Co) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LLY
- LILLY ENDOWMENT INC 90.07M sh · $104.21B · Q3 2026
- Vanguard Group 81.97M sh · $88.09B · Q4 2025
- BlackRock Inc 67.54M sh · $81.01B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 53.53M sh · $64.20B · Q2 2026
- PNC Financial Services 51.32M sh · $61.56B · Q2 2026
- Fidelity Management & Research (FMR) 28.46M sh · $34.14B · Q2 2026
- STATE STREET CORP 35.61M sh · $32.75B · Q1 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 20.86M sh · $25.02B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 20.31M sh · $24.28B · Q2 2026
- Geode Capital Management 20.31M sh · $24.28B · Q2 2026
More on Eurizon Capital SGR S.p.A.
FAQ
How long has Eurizon Capital SGR S.p.A. held LLY?
Eurizon Capital SGR S.p.A. has disclosed LLY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Eurizon Capital SGR S.p.A.'s current position in LLY?
As of Q3 2026, Eurizon Capital SGR S.p.A. holds 417.65K shares of LLY (Eli Lilly & Co), valued at $485.58M, representing 1.29% of its reported portfolio and ranking #14.
Has Eurizon Capital SGR S.p.A. been buying or selling LLY?
In the latest 13F filing (Q3 2026), Eurizon Capital SGR S.p.A. reduced its position in LLY.
Which other funds hold LLY?
Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.